Correlation of Mukbang Video Watching Behavior,Internet Addition and Mental Health Among Adolescent and Youth
Launched by SUN YAT-SEN UNIVERSITY · Jul 27, 2022
Trial Information
Current as of October 16, 2025
Unknown status
Keywords
ClinConnect Summary
Adolescence and Youth is a critical period for psychological quality training and personality shaping, and their mental health has always been the focus of health management for this population. With the rapid development of short videos and self-media, watching "Mukbang" is a behavioral way for these people to relieve anxiety, depression and other mental health problems. But watching "Mukbang" behaviors may have Internet addiction, and there is a high comorbidity rate between Internet addiction and mental health disorders. "Mukbang" is a newly developed online entertainment method. Its hel...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Internet users aged 14-35；
- • Be able to read and communicate in Chinese.
- Exclusion Criteria:
- • Those who cannot complete communication due to serious mental or physical diseases such as deafness, unclear consciousness caused by mental illness, etc.
About Sun Yat Sen University
Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Wei Xia, PhD
Principal Investigator
Sun Yat-sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials